Lyra Therapeutics (LYRA) Misses Q3 EPS by 338c

Lyra Therapeutics (NASDAQ: LYRA) reported Q3 EPS of ($3.38).

For earnings history and earnings-related data on Lyra Therapeutics (LYRA) click here.

You May Also Be Interested In

• Bernstein SocGen Group Starts SSE Plc. (SSE:LN) (SSEZY) at Outperform
• JPMorgan Reiterates Overweight Rating on Adani Ports & Special Economic Zone (ADSEZ:IN)
• C3.ai (AI) Tops Q1 EPS by 5c; Offers Guidance